These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36584692)

  • 1. Optimization of Phenylalanine Cut-Off Value in Newborn Screening Based on Blood Sampling Time.
    Liu Z; Jin H; Ye M; Han R; Han N; Zhao J
    Am J Perinatol; 2024 May; 41(S 01):e995-e1000. PubMed ID: 36584692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing the Phenylalanine Cut-Off Value in a Newborn Screening Program.
    Perko D; Repic Lampret B; Remec ZI; Zerjav Tansek M; Drole Torkar A; Krhin B; Bicek A; Oblak A; Battelino T; Groselj U
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 6-year application of the enzymatic colorimetric phenylalanine assay in the setting of neonatal screening for phenylketonuria.
    Schulze A; Mayatepek E; Hoffmann GF
    Clin Chim Acta; 2002 Mar; 317(1-2):27-37. PubMed ID: 11814455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated phenylalanine on newborn screening: follow-up testing may reveal undiagnosed galactosaemia.
    Shakespeare L; Downing M; Allen J; Casbolt AM; Ellin S; Maloney M; Race G; Bonham J
    Ann Clin Biochem; 2010 Nov; 47(Pt 6):567-9. PubMed ID: 20947531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours.
    Chace DH; Sherwin JE; Hillman SL; Lorey F; Cunningham GC
    Clin Chem; 1998 Dec; 44(12):2405-9. PubMed ID: 9836704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous diagnostic method for phenylketonuria and galactosemia from dried blood spots using high-performance liquid chromatography-pulsed amperometric detection.
    Kim NH; Jeong JS; Kwon HJ; Lee YM; Yoon HR; Lee KR; Hong SP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(21):1860-4. PubMed ID: 20494631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening for hyperphenylalaninemia on day 5: is 240 mumol/liter the most appropriate cut-off level?
    Clemens PC; Neumann SJ; Wulke AP; Burmester JG
    Prev Med; 1990 Jan; 19(1):54-60. PubMed ID: 2181433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of electrospray-tandem mass spectrometry using the phenylalanine/tyrosine-ratio for differential diagnosis of hyperphenylalaninemia in neonates.
    Schulze A; Kohlmueller D; Mayatepek E
    Clin Chim Acta; 1999 May; 283(1-2):15-20. PubMed ID: 10404727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Tandem Mass Spectrometry and the Fluorometric Method-Parallel Phenylalanine Measurement on a Large Fresh Sample Series and Implications for Newborn Screening for Phenylketonuria.
    Perko D; Groselj U; Cuk V; Iztok Remec Z; Zerjav Tansek M; Drole Torkar A; Krhin B; Bicek A; Oblak A; Battelino T; Repic Lampret B
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cuban neonatal screening of phenylketonuria using an ultramicro-fluorometric test.
    González EC; Frómeta A; del Río L; Castells E; Robaina MS; García SM; Licourt T; Arteaga AL; Martínez L
    Clin Chim Acta; 2009 Apr; 402(1-2):129-32. PubMed ID: 19168043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Did the change of technique of screening investigations influence on improvement of test credibility in recognizing and differentiating diagnostics of hiperphenylalaninemias?].
    Didycz B; Lemańska D; Słuszniak A
    Przegl Lek; 2009; 66(1-2):11-3. PubMed ID: 19485249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn phenylketonuria (PKU) Guthrie (BIA) screening and early hospital discharge.
    Hanley WB; Demshar H; Preston MA; Borczyk A; Schoonheyt WE; Clarke JT; Feigenbaum A
    Early Hum Dev; 1997 Jan; 47(1):87-96. PubMed ID: 9118832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal phenylalanine wash-out in phenylketonuria.
    Porta F; Ponzone A; Spada M
    Metab Brain Dis; 2020 Oct; 35(7):1225-1229. PubMed ID: 32661828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.
    Giżewska M; MacDonald A; Bélanger-Quintana A; Burlina A; Cleary M; Coşkun T; Feillet F; Muntau AC; Trefz FK; van Spronsen FJ; Blau N
    Eur J Pediatr; 2016 Feb; 175(2):261-72. PubMed ID: 26350228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal birth parameters of positive newborns at PKU screening as predictors of false-positive and positive results at recall-testing.
    Zaffanello M; Zamboni G; Maffeis C; Tatò L
    J Med Screen; 2003; 10(4):181-3. PubMed ID: 14738655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening of phenylketonuria using direct analysis in real time (DART) mass spectrometry.
    Wang C; Zhu H; Cai Z; Song F; Liu Z; Liu S
    Anal Bioanal Chem; 2013 Apr; 405(10):3159-64. PubMed ID: 23397086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insurance Reimbursement for Special Foods and Phenylalanine Levels in Patients With PKU in China.
    Wang B; Xia Y; Cheng M; Luo H; Xue L; Gong A; Liu X; Liao G; Song J; Ning K
    JAMA Netw Open; 2024 Jun; 7(6):e2412886. PubMed ID: 38837161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of effectiveness and outcome of PKU screening and management in the State of Sergipe, Brazil.
    Ramalho AR; Ramalho RJ; Oliveira CR; Magalhães MM; Santos EG; Sarmento PM; Matos DO; Oliveira MC; Oliveira AL; Aguiar-Oliveira MH
    Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):62-7. PubMed ID: 24728166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis.
    Aydemir C; Aydemir H; Kokturk F; Kulah C; Mungan AG
    BMC Pediatr; 2018 Aug; 18(1):253. PubMed ID: 30068303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the phenylalanine:tyrosine ratio to test newborns for phenylketonuria in a large public health screening programme.
    Eastman JW; Sherwin JE; Wong R; Liao CL; Currier RJ; Lorey F; Cunningham G
    J Med Screen; 2000; 7(3):131-5. PubMed ID: 11126161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.